43742-2359 NDC - FEMALE STIMULANT (ACONITICUM ACIDUM, CIS-, APIS VENENUM PURUM, AQUILEGIA VULGARIS, BOVISTA, CYPRIPEDIUM PUBESCENS, ESTRADIOL, FAECALIS (ALKALIGENES), FOLLICULINUM, FUNICULUS UMBILICALIS SUIS, GLANDULA SUPRARENALIS SUIS, HEART (SUIS), HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, KREOSOTUM, LACHESIS MUTUS, LILIUM TIGRINUM, MAGNESIA PHOSPHORICA, MERCURIUS SOLUBILIS, MUTABILE BACILLUS (BACH), OOPHORINUM (SUIS), PETROSELINUM SATIVUM, PINEAL GLAND (SUIS), PLACENTA TOTALIS SUIS, PROGESTERONE, SEPIA, TESTOSTERONE, UTERUS (SUIS))

Drug Information

  • Product NDC: 43742-2359
  • Proprietary Name: Female Stimulant
  • Non Proprietary Name: Aconiticum Acidum, Cis-, Apis Venenum Purum, Aquilegia Vulgaris, Bovista, Cypripedium Pubescens, Estradiol, Faecalis (Alkaligenes), Folliculinum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (Suis), Hydrastis Canadensis, Hypophysis Suis, Kreosotum, Lachesis Mutus, Lilium Tigrinum, Magnesia Phosphorica, Mercurius Solubilis, Mutabile Bacillus (Bach), Oophorinum (Suis), Petroselinum Sativum, Pineal Gland (Suis), Placenta Totalis Suis, Progesterone, Sepia, Testosterone, Uterus (Suis)
  • Active Ingredient(s): 20 [hp_X]/mL ACONITIC ACID, (Z)-; 30 [hp_C]/mL ALCALIGENES FAECALIS; 18 [hp_X]/mL APIS MELLIFERA VENOM; 8 [hp_X]/mL AQUILEGIA VULGARIS; 6 [hp_X]/mL CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; 30 [hp_C]/mL ESCHERICHIA COLI; 30 [hp_X]/mL ESTRADIOL; 8 [hp_X]/mL ESTRONE; 6 [hp_X]/mL GOLDENSEAL; 10 [hp_X]/mL LACHESIS MUTA VENOM; 4 [hp_X]/mL LILIUM LANCIFOLIUM WHOLE FLOWERING; 6 [hp_X]/mL LYCOPERDON UTRIFORME FRUITING BODY; 10 [hp_X]/mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; 10 [hp_X]/mL MERCURIUS SOLUBILIS; 6 [hp_X]/mL PETROSELINUM CRISPUM WHOLE; 8 [hp_X]/mL PORK HEART; 30 [hp_X]/mL PROGESTERONE; 10 [hp_X]/mL SEPIA OFFICINALIS JUICE; 8 [hp_X]/mL SUS SCROFA ADRENAL GLAND; 8 [hp_X]/mL SUS SCROFA OVARY; 12 [hp_X]/mL SUS SCROFA PINEAL GLAND; 13 [hp_X]/mL SUS SCROFA PITUITARY GLAND; 6 [hp_C]/mL SUS SCROFA PLACENTA; 8 [hp_X]/mL SUS SCROFA UMBILICAL CORD; 8 [hp_X]/mL SUS SCROFA UTERUS; 30 [hp_X]/mL TESTOSTERONE; 8 [hp_X]/mL WOOD CREOSOTE
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Androgen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]; Calculi Dissolution Agent [EPC]; Estradiol Congeners [CS]; Estrogen Receptor Agonists [MoA]; Estrogen [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Progesterone [CS]; Progesterone [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Field Name Field Value
Labeler Name: Deseret Biologicals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:2/19/2026
DEA Schedule:CIII

Package Information

No. Package Code Package Description Billing Unit
143742-2359-130 mL in 1 BOTTLE, DROPPER (43742-2359-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43742-2359The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEFemale StimulantThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAconiticum Acidum, Cis-, Apis Venenum Purum, Aquilegia Vulgaris, Bovista, Cypripedium Pubescens, Estradiol, Faecalis (Alkaligenes), Folliculinum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (Suis), Hydrastis Canadensis, Hypophysis Suis, Kreosotum, Lachesis Mutus, Lilium Tigrinum, Magnesia Phosphorica, Mercurius Solubilis, Mutabile Bacillus (Bach), Oophorinum (Suis), Petroselinum Sativum, Pineal Gland (Suis), Placenta Totalis Suis, Progesterone, Sepia, Testosterone, Uterus (Suis)The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE2/19/2026This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDeseret Biologicals, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACONITIC ACID, (Z)-; ALCALIGENES FAECALIS; APIS MELLIFERA VENOM; AQUILEGIA VULGARIS; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; ESCHERICHIA COLI; ESTRADIOL; ESTRONE; GOLDENSEAL; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; PETROSELINUM CRISPUM WHOLE; PORK HEART; PROGESTERONE; SEPIA OFFICINALIS JUICE; SUS SCROFA ADRENAL GLAND; SUS SCROFA OVARY; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA UTERUS; TESTOSTERONE; WOOD CREOSOTEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH20; 30; 18; 8; 6; 30; 30; 8; 6; 10; 4; 6; 10; 10; 6; 8; 30; 10; 8; 8; 12; 13; 6; 8; 8; 30; 8 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAndrogen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Calculi Dissolution Agent [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Progesterone [CS], Progesterone [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] 
DEA SCHEDULECIIIThis is the assigned DEA Schedule number as reported by the labeler. Values are CI, CII, CIII, CIV, and CV.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 2/21/2026

Previous Code
Next Code